Elevated baseline PTH, which was influential in the lumbar model, predicted a poorer spine response, underscoring the importance of ensuring sufficient vitamin D and calcium before initiating therapy—not only to correct secondary hyperparathyroidism but also to optimize bone metabolism and the anabolic response (Reid et al., 1995; Drake et al., 2017). This evidence concerns the gene PTH and secondary hyperparathyroidism.